한글목차

• 예측 기간 동안 주요 7개 시장(미국, 유럽 5개국, 일본)에서 RH 진단을 받은 환자 수는 전반적으로 증가할 것으로 예측됩니다.
• 많은 치료 옵션이 있으며, 특히 ACE 억제제와 ARB 카테고리에서는 저렴한 비용과 접근성으로 인해 제네릭 의약품이 선호되고 있습니다.
• RH 시장에는 임상적 측면과 환경적 측면에서 여전히 큰 미충족 수요가 존재합니다.
• 주요 7개 시장의 RH 시장 규모는 2024년 26억 달러로 2034년까지 135억 달러에 달할 것으로 예상되며, 연평균 17.3%의 성장률을 보일 것으로 예측됩니다.

본 보고서는 치료 저항성 고혈압(RH)의 7대 주요 시장에 대해 조사했으며, 질환 개요, 시장 수익 예측, 파이프라인 분석, 현재 및 향후 경쟁 분석 등을 전해드립니다.

목차

• 주요 요약
• 질환 개요
• 역학
• 현재 치료 옵션
• 미충족 요구와 기회
• 연구개발 전략
• 파이프라인 평가
• 시장 전망

부록

영문목차

This report covers the 7MM (US, 5EU, Japan) and provides an Excel-based forecast model for the RH market through 2034.

• There will be an overall increase in the diagnosed prevalent cases of RH in the 7MM across the forecast period.
• There are many treatment options available, particularly in the ACE inhibitor and ARB classes, where genericized therapies are favoured due to their low cost and wider availability.
• Significant clinical and environmental unmet needs remain in the RH market.
• The RH market across the 7MM was valued at $2.6 billion in 2024 and is expected to grow to $13.5 billion by 2034 at a compound annual growth rate (CAGR) of 17.3%.

Scope

• Overview of RH, including epidemiology, symptoms, diagnosis, and disease management.
• Annualized RH therapeutics market revenue in 7MM (US, 5EU, and Japan), annual cost of therapy and treatment usage pattern in 2024 and forecast for 10 years to 2034.
• Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the RH therapeutics market.
• Pipeline analysis, comprehensive data assessing emerging trends and mechanisms of action under development for RH treatment. The most promising candidates in late-stage development are profiled.
• Analysis of the current and future market competition in the 7MM RH therapeutics market. Insightful review of the key industry drivers, restraints, and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the RH therapeutics market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the RH therapeutics market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents

Table of Contents

• Executive Summary
• Disease Overview
• Epidemiology
• Current Treatment Options
• Unmet Needs and Opportunities
• R&D Strategies
• Pipeline Assessment
• Market Outlook

Appendix

• Contact Us